| Megan K Sebasco, MS, CCC-SLP | |
|
7 Memorial Dr, Somersworth, NH 03878-1896 | |
| (603) 692-2126 | |
| Not Available |
| Full Name | Megan K Sebasco |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7 Memorial Dr, Somersworth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841917598 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1982 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan K Sebasco, MS, CCC-SLP 16 Garland Rd, Nottingham, NH 03290-6109 Ph: (856) 340-1243 | Megan K Sebasco, MS, CCC-SLP 7 Memorial Dr, Somersworth, NH 03878-1896 Ph: (603) 692-2126 |
News Archive
Recently, Brazil has steadily climbed the chart of the top 10 countries with the highest total of COVID19 cases, now ranking number two just behind the US.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.
NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial.
Celgene International Sà rl, a subsidiary of Celgene Corporation, (NASDAQ: CELG), announced final results from a phase II investigational study evaluating the combination of REVLIMID® (lenalidomide) and rituximab in 59 patients with relapsed or refractory chronic lymphocytic leukemia (CLL). These data were presented at the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.
It has now been 15 years since scientists celebrated the completion of the human genome. At that point, scientists had determined the entire sequence of the genetic letters making up our DNA.
› Verified 8 days ago
Victoria A Mogol, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 46 Stackpole Rd, Somersworth, NH 03878 Phone: 603-692-2435 | |
Catherine Francoeur, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Coles Pond Rd, Somersworth, NH 03878 Phone: 207-251-1213 | |
Maria E. Kirby, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Cinnamon Ridge Rd, Somersworth, NH 03878 Phone: 603-359-3513 | |
Ivy Marie Boggs, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 317 Main St, Somersworth, NH 03878 Phone: 603-692-4411 Fax: 603-692-6717 | |
Vani Krishnan, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 61 W High St, Somersworth, NH 03878 Phone: 603-498-4419 | |
Cherise Tompkins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 109 Rocky Hill Rd, Somersworth, NH 03878 Phone: 603-494-1386 |